Gene Query: QSOX1

Dataset Description Geneva Score
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 83.28
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 80.61
Rorc disruption in human FG pancreatic cancer cells 57.58
Gene Expression Profiling of SPOP Knocked Down Cell 49.37
Genome wide expression change in LCC2 and MCF-7 cells 48.41
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 47.81
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 45.31
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 45.31
DJ-1 is dispensable for human stem cell homeostasis 44.41
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 44.11
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 43.97
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 43.97
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 42.58
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 42.34
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 42.31
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 41.65
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 41.65
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 41.28
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 38.77
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 38.47
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 38.42
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 37.28
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 36.36
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 35.81
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 35.74
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 35.22
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 35.22
Global analyses of the effect of different cellular contexts on microRNA targeting 35.18
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 35.18
Gene expression analysis in response to hypoxic pathway inhibition 34.1
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 31.9
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 31.57
Dtx3L and Androgen Signaling in Prostate Cancer 31.2
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 31.04
RNA sequencing of GlyH-101-treated MCF-7 cell line 30.41
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 30.07
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 30.07
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 29.9
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 29.81
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 29.72
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 29.24
RNA-Seq analysis of breast cancer cells after shikonin treatment 28.95
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 28.6
Hypoxic transcriptome of SQ20B human head and neck cancer cells 28.59
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 28.06
A role for ZNF598 in post-transcriptional gene regulation 27.4
MYCi975 regulates MYC target genes 27.32
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 27.1
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 27.06
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 26.89
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 26.84
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 25.74
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 25.74
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 25.2
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 24.86
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 24.86
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 24.78
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 24.77
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 24.61
Effect of BMP inhibition or stimulation of primary human keratinocytes 24.61
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 24.26
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 24.23
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 24.19
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 23.03
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 22.98
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 22.92
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 22.91
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 22.82
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 22.82
Modeling Familial Cancer with iPSC Approaches 22.54
IDH3a KO RNA-seq 22.08
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 22.01
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 21.97
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 21.75
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 21.44
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 21.3
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 21.12
Nutritional control of protein translation 21.01
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 20.86
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 20.8
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 20.67
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 20.65
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 20.12
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 20.12
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 20.1
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 20.04
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 19.86
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 19.84
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 19.84
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 19.83
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 19.8
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 19.77
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 19.61
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 19.61
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 19.44
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 19.32
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 19.16
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 18.96
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 18.93
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 18.87
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 18.86
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 18.8
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 18.68
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 18.68
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 18.64
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 18.62
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 18.61
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 18.61
Genome-wide chromatin analysis of Ewing sarcoma 18.58
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 18.58
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 18.51
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 18.24
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 18.02
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 17.94
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 17.9
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 17.85
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 17.77
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 17.68
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 17.67
Transcriptome profiling of 5 human adenocarcinoma cell lines 17.58
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 17.54
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 17.52
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 17.41
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 17.34
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 17.27
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 17.16
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 17.09
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 17.09
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 16.98
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 16.97
Gene expression analysis of human liver progenitor-like cells in culture 16.94
High level DNA repair gene expression in human ES cells 16.93
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 16.72
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 16.72
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 16.61
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 16.61
Gene expression profiling of leukemia cells following asparagine depletion 16.57
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 16.56
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 16.56
RNA seq with AML (NB4) cells upon FTO inhibition 16.42
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 16.22
Transcription control by the ENL YEATS domain in acute leukemia 16.22
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 16.16
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 16.08
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 16.08
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 16.08
RNA sequencing with KSHV infection and enrichment for circular RNAs 16.0
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 15.98
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 15.93
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 15.93
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 15.83
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 15.83
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 15.74
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 15.56
MCF10A H-Ras RNA-Seq 15.53
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 15.51
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 15.39
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 15.39
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 15.35
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 15.33
Ribosomal footprinting of MDA-Parental and MDA-LM2 15.22
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 15.22
Ribosomal footprinting of CN34-Parental and CN34-LM1a 15.16
Metastasis in triple-negative breast cancer 15.14
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 15.14
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 15.06
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 15.06
Morphological and molecular characterization of human dermal lymphatic collectors 15.06
Human cells contain natural double-stranded RNAs with potential regulatory capacity 15.02
RNA-seq analyses of human prostate cancer cells 14.91
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 14.9
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 14.8
Role of CD133 molecule in WNT response and renal repair 14.78
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 14.73
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 14.69
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 14.69
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 14.63
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 14.55
MOF acetyl transferase regulates transcription and respiration in mitochondria 14.52
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 14.4
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 14.31
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 14.12
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 14.01
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 13.94
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 13.9
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 13.83
Gene expression profile of human placenta from T. Cruzi infected mothers 13.78
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 13.67
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 13.58
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 13.57
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 13.56
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 13.56
TGF-β regulation of miRNA expression in pancreatic cancer 13.49
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 13.45
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 13.44
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 13.4
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 13.39
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 13.28
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 13.27
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 13.27
Regulation of highly expressed hCINAP on translatome 13.22
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 13.15
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 13.12
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 13.11
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 13.11
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 13.1
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 13.07
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 13.02
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 12.98
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 12.94
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 12.84
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 12.78
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 12.73
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 12.71
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 12.62
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 12.59
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 12.56
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 12.55
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 12.43
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 12.41
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 12.39
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 12.37
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 12.22
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 12.16
Transcriptome-wide identification of CELF2 functional targets in T cells 12.15
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 12.11
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 12.1
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 12.09
The human blood-nerve barrier transcriptome 12.09
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 12.06
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 12.02
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 12.02
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 11.99
Selective expression of long non-coding RNAs in a breast cancer cell progression model 11.92
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 11.8
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 11.8
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 11.77
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 11.77
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 11.74
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 11.73
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 11.72
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 11.69
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 11.59
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 11.49
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 11.44
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 11.42
Non-coding regions are the main source of tumor-specific antigens [human] 11.36
Non-coding regions are the main source of tumor-specific antigens 11.36
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 11.35
EWS-Fli and LNC regulated genes in comparison to GFP samples 11.33
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 11.32
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 11.32
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 11.24
CircRNAome diversity in human mature B-cells, T-cells and monocytes 11.18
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 11.13
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 11.13
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 11.08
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 11.08
RNA-seq of cancer cell lines treated with T-025 11.06
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 11.04
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 11.04
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 10.99
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 10.94
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 10.94
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 10.87
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 10.81
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 10.78
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 10.78
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 10.76
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 10.71
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 10.62
Postnatal lipids drive hepatocyte maturation 10.59
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 10.56
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 10.52
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 10.47
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 10.47
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 10.46
Gene expression profiling of human and murine in vitro muscle differentiation 10.42
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 10.37
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 10.25
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 10.25
Enhancer activation during EGF response 10.23
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 10.09
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 10.02
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 9.95
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 9.93
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 9.93
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 9.93
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 9.84
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 9.82
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 9.76
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 9.75
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 9.75
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 9.74
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 9.66
HNRNPM-regulated splicing dependencies in prostate cancer 9.65
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 9.65
BACH2 in human plasma cell fate decision 9.59
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 9.52
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 9.46
Gene expression patterns define the hepatocyte-like cells derived by different strategies 9.46
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 9.46
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 9.46
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 9.33
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 9.24
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 9.05
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 9.0
The pioneer factor CEBPA modulates vitamin D signaling 9.0
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 8.97
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 8.96
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 8.93
Exploring the RNA landscape of endothelial exosomes 8.77
Effect of nuclear IL-33 on gene expression 8.7
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 8.45
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 8.43
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 8.42
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 8.34
mRNA expression in human DAOY cells 8.28
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 8.07
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 8.07
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 8.06
Activity-dependent transcriptional changes in human neurons 7.98
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 7.97
ZIKV infection of monocytes activates inflammasome pathways 7.92
An siRNA screen identifies CHD4 as a target for epigenetic therapy 7.86
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 7.85
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 7.85
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 7.66
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 7.35
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 7.32
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 7.31
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 7.23
Induced DNA demethylation, genome instability and transcription 7.18
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 7.18
Interaction between mitoNEET and NAF-1 in cancer cells 7.16
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 6.97
Positively selected enhancer elements endow tumor cells with metastatic competence 6.96
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 6.95
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 6.89
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 6.89
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 6.87
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 6.86
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 6.74
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 6.74
Alagille_Nodder 6.67
RNA Seq of Alagille liver biopsies 6.67
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 6.65
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 6.65
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 6.64
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 6.63
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 6.63
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 6.51
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 6.43
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 6.29
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 6.29
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 6.23
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 6.16
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 6.14
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 6.13
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 6.1
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 6.1
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 6.08
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 6.04
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 6.04
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 5.98
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 5.92
Toxoplasma gondii infection of human retinal pigment epithelial cells 5.86
Gene profiling of human adult and pediatric liver cancer cells 5.81
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 5.8
ARS2 is a general suppressor of pervasive transcription [RNAseq] 5.8
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 5.8
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 5.8
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 5.78
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 5.78
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 5.59
A practical evaluation of alignment algorithms for RNA variant calling analysis 5.47
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 5.34
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 5.34
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 5.24
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 5.23
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 5.15
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 5.06
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.97
U2AF1 mutations alter splice site recognition in hematological malignancies 4.94
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 4.85
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 4.8
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 4.8
Common inflammatory pathways between NEC and Crohn's disease 4.8
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 4.76
RNA-seq of SCLC PDX models treated with EP 4.72
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 4.7
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 4.69
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 4.58
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 4.58
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 4.54
Zika virus infection reprograms global transcription of host cells to allow sustained infection 4.54
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 4.52
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 4.52
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 4.46
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 4.44
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 4.39
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 4.35
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 4.35
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 4.26
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 4.23
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 4.16
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 4.08
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 4.08
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 3.99
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 3.98
A single-cell transcriptome atlas of the human pancreas 3.94
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 3.93
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 3.87
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 3.86
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 3.86
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 3.82
Gene expression profiling in metabolically heterogeneous human lung tumors 3.76
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 3.62
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 3.58
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 3.58
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 3.37
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 3.24
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 3.24
Be1 and Be2 B cells are transcriptionally distinct 3.24
siRNA-mediated knockdown 3.19
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 3.18
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 3.18
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 3.14
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 3.12
Differences in miRNA Detection Levels are Technology and Sequence Dependent 3.11
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 3.11
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 3.08
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 2.99
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 2.99
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 2.97
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 2.95
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 2.79
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.67
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 2.66
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 2.65
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 2.62
Evaluating pre-clinical models for studying NASH driven HCC. 2.56
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 2.54
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 2.38
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.29
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.25
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.22
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 2.14
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 2.06
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.99
Loss of endometrial plasticity in recurrent pregnancy loss 1.92
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 1.92
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 1.91
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 1.91
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.89
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.87
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 1.82
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.8
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 1.77
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.62
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.62
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.6
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 1.6
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.45
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.45
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.44
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 1.44
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.43
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.36
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.34
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.34
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 1.33
RNA expression profiles comparing primary and omental ovarian carcinoma samples 1.29
Trascriptome of thyroid cancer-induced macrophages 1.25
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 1.25
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 1.2
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 1.16
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 1.11
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.9
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.78
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 0.76
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.72
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.7
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.7
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.66
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.66
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.65
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.63
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 0.57
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.46
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.45
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.4
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.37
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.21
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 0.19
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.19
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.19
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 0.16
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.08
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.04


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation